Molecular Insights into the Pathogenesis and Treatment of Huntington’s and Alzheimer’s Diseases
Event Details
- Type
- Monday Lecture Series
- Speaker(s)
-
Nathaniel Heintz, James and Marilyn Simons Professor, director, Fisher Center for Alzheimer’s Research and head, Laboratory of Molecular Biology, The Rockefeller University
- Speaker bio(s)
-
Development of effective therapies for late onset neurodegenerative disease has been largely unsuccessful. The focus of this discussion will be the integration of cell type specific transcriptional and epigenetic data from human brain cell types with emerging human genetics studies to generate novel therapeutic initiatives for human late onset neurological diseases. The lecture will discuss novel cell type specific strategies for modulation of pathways that can slow or halt progression of these diseases and therapeutic initiatives designed to restore circuit functions despite ongoing neuronal loss.
Nathaniel Heintz graduated from Williams College with a B.A. in biology in 1974. He received his Ph.D. from the State University of New York, Albany, in 1979 and then worked as a postdoc at Washington University in St. Louis until 1982. He came to Rockefeller as assistant professor in 1983 and was named associate professor in 1987, professor in 1992, and James and Marilyn Simons Professor in 2006. He became a Howard Hughes Medical Institute investigator in 1992. Heintz is a member of the National Academy of Sciences. In 2022, Heintz was appointed as the Director of the Fisher Center for Alzheimer's Disease Research.
- Open to
- Campus Only